EBS - Emergent BioSolutions Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue560,873488,782489,331404,466
Cost of Revenue293,091239,574216,845206,684
Gross Profit267,782249,208272,486197,782
Operating Expenses
Research Development----
Selling General and Administrative140,957134,000121,145108,594
Non Recurring----
Others----
Total Operating Expenses434,048373,574337,990315,278
Operating Income or Loss126,825115,208151,34189,188
Income from Continuing Operations
Total Other Income/Expenses Net-8,192-15,987-15,625-4,994
Earnings Before Interest and Taxes126,825115,208151,34189,188
Interest Expense-6,590-7,617-6,523-8,240
Income Before Tax118,63399,221135,71684,194
Income Tax Expense36,03936,69744,30029,928
Minority Interest----
Net Income From Continuing Ops82,59462,52491,41654,266
Non-recurring Events
Discontinued Operations--10,748-28,546-17,525
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income82,59451,77662,87036,741
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares82,59451,77662,87036,741